Dividend Logo Green Small
MENU
Advertisement.

ALT:Altimmune Inc - Stock Price Quote and Dividend Data

ALT STOCK PRICE LATEST CLOSE

$4.16

EXCHANGE

NASDAQ

ALT

Altimmune Inc Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Stock Split Date & FactorSep. 14, 2018 & 30.0000
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
ALT

Altimmune Inc Stock Price Information

ALT Stock Price Latest Close$4.16
52-Week Low/High Stock Price$3.55 - $11.16
Percent Held by Institutions77.25%
Revenue$25,000
Net Income$-118,239,000
Cash Flow$-98,113,000
EPS-0.33%
Market Cap$320,378,240
PE Ratio0
PE Ratio to Industry119%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-48.06%
Total Return Last 3 Years-26.76%
Total Return Last 5 Years31.23%
Latest Trade DateApr. 10, 2025
ALT

Altimmune Inc Annual Stock Dividends

No Data available for Payment History.

ALT

Altimmune Inc Dividend Payment History

No dividends retrieved for ALT
ALT

Altimmune Inc Other Dividend Details

Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Co.'s lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). Co. has completed the MOMENTUM Phase II obesity trial and is being studied in the IMPACT Phase IIb MASH trial. It is also developing HepTcell, an immunotherapeutic product candidate for patients chronically infected with the hepatitis B virus (HBV). Co. has completed the enrollment in its Phase II clinical trial of HepTcell.

Web Sitewww.altimmune.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Altimmune Inc Dividend Stock News and Updates

Apr. 10, 2025ALT STOCK PRICE INCREASE: Altimmune Inc on 04-10-2025 increased stock price > 10% from $3.67 to $4.23

Mar. 15, 2025ALT STOCK PRICE INCREASE: Altimmune Inc on 03-15-2025 increased stock price > 10% from $5.20 to $5.92

Dec. 05, 2024ALT STOCK PRICE INCREASE: Altimmune Inc on 12-05-2024 increased stock price > 10% from $8.79 to $9.85

Nov. 15, 2024ALT STOCK PRICE DECREASE: Altimmune Inc on 11-15-2024 decreased stock price > 10% from $9.52 to $8.45

Nov. 13, 2024ALT STOCK PRICE INCREASE: Altimmune Inc on 11-13-2024 increased stock price > 10% from $7.35 to $9.49

Sep. 14, 2024ALT STOCK PRICE INCREASE: Altimmune Inc on 09-14-2024 increased stock price > 10% from $7.10 to $7.88

Aug. 20, 2024ALT STOCK PRICE INCREASE: Altimmune Inc on 08-20-2024 increased stock price > 10% from $6.49 to $7.54

Aug. 09, 2024ALT STOCK PRICE INCREASE: Altimmune Inc on 08-09-2024 increased stock price > 10% from $5.50 to $6.33

Jul. 19, 2024ALT STOCK PRICE DECREASE: Altimmune Inc on 07-19-2024 decreased stock price > 10% from $7.49 to $6.55

Jun. 27, 2024ALT STOCK PRICE DECREASE: Altimmune Inc on 06-27-2024 decreased stock price > 10% from $7.41 to $6.26

More Altimmune Inc Dividend News
Biotechnology Dividend Stock News and Updates

Apr. 11, 2025DIVIDEND RATE INCREASE: ADR (Sponsored)/CSL Ltd (OTCBB: CSLLY) on 04-11-2025 increased dividend rate > 3% from $1.22 to $1.28

Apr. 11, 2025KRBPQ STOCK PRICE DECREASE: Kiromic BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.12 to $0.08

Apr. 11, 2025OMGAQ STOCK PRICE DECREASE: Omega Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.04

Apr. 11, 2025ALGS STOCK PRICE DECREASE: Aligos Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.03 to $3.99

Apr. 11, 2025ATRA STOCK PRICE DECREASE: Atara Biotherapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.89 to $5.30

Apr. 11, 2025ZVSA STOCK PRICE DECREASE: Com Par $0.001/ZyVersa Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $1.03 to $0.77

Apr. 11, 2025GERNW STOCK PRICE DECREASE: Wt Pur Com Exp 12/31/2025/Geron Corp. on 04-11-2025 decreased stock price > 10% from $0.30 to $0.27

Apr. 11, 2025RVMDW STOCK PRICE DECREASE: Wt Exp/Revolution Medicines Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.03

Apr. 11, 2025ELUT STOCK PRICE DECREASE: Cl A Com/Elutia Inc on 04-11-2025 decreased stock price > 10% from $2.49 to $2.24

Apr. 11, 2025QNRX STOCK PRICE DECREASE: Sponsored ADR (New)/Quoin Pharmaceuticals Ltd on 04-11-2025 decreased stock price > 10% from $6.89 to $5.49

More Biotechnology Dividend News
X
Search Dividend Investor